515 related articles for article (PubMed ID: 26194320)
1. Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014.
Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Cedarbaum J; Donohue MC; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw L; Thompson PM; Toga AW; Trojanowski JQ;
Alzheimers Dement; 2015 Jul; 11(7):865-84. PubMed ID: 26194320
[TBL] [Abstract][Full Text] [Related]
2. Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative.
Veitch DP; Weiner MW; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ;
Alzheimers Dement; 2019 Jan; 15(1):106-152. PubMed ID: 30321505
[TBL] [Abstract][Full Text] [Related]
3. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.
Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Liu E; Morris JC; Petersen RC; Saykin AJ; Schmidt ME; Shaw L; Shen L; Siuciak JA; Soares H; Toga AW; Trojanowski JQ;
Alzheimers Dement; 2013 Sep; 9(5):e111-94. PubMed ID: 23932184
[TBL] [Abstract][Full Text] [Related]
4. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.
Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Liu E; Morris JC; Petersen RC; Saykin AJ; Schmidt ME; Shaw L; Siuciak JA; Soares H; Toga AW; Trojanowski JQ;
Alzheimers Dement; 2012 Feb; 8(1 Suppl):S1-68. PubMed ID: 22047634
[TBL] [Abstract][Full Text] [Related]
5. Introduction to special issue: Overview of Alzheimer's Disease Neuroimaging Initiative.
Weiner MW; Veitch DP
Alzheimers Dement; 2015 Jul; 11(7):730-3. PubMed ID: 26194308
[TBL] [Abstract][Full Text] [Related]
6. Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials.
Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ;
Alzheimers Dement; 2017 Apr; 13(4):e1-e85. PubMed ID: 28342697
[TBL] [Abstract][Full Text] [Related]
7. The Alzheimer's Disease Neuroimaging Initiative in the era of Alzheimer's disease treatment: A review of ADNI studies from 2021 to 2022.
Veitch DP; Weiner MW; Miller M; Aisen PS; Ashford MA; Beckett LA; Green RC; Harvey D; Jack CR; Jagust W; Landau SM; Morris JC; Nho KT; Nosheny R; Okonkwo O; Perrin RJ; Petersen RC; Rivera Mindt M; Saykin A; Shaw LM; Toga AW; Tosun D;
Alzheimers Dement; 2024 Jan; 20(1):652-694. PubMed ID: 37698424
[TBL] [Abstract][Full Text] [Related]
8. The Alzheimer's Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plans.
Kang JH; Korecka M; Figurski MJ; Toledo JB; Blennow K; Zetterberg H; Waligorska T; Brylska M; Fields L; Shah N; Soares H; Dean RA; Vanderstichele H; Petersen RC; Aisen PS; Saykin AJ; Weiner MW; Trojanowski JQ; Shaw LM;
Alzheimers Dement; 2015 Jul; 11(7):772-91. PubMed ID: 26194312
[TBL] [Abstract][Full Text] [Related]
9. The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement.
Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Salazar J; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ;
Alzheimers Dement; 2017 May; 13(5):561-571. PubMed ID: 27931796
[TBL] [Abstract][Full Text] [Related]
10. The impact of the Alzheimer's Disease Neuroimaging Initiative 2: What role do public-private partnerships have in pushing the boundaries of clinical and basic science research on Alzheimer's disease?
Jones-Davis DM; Buckholtz N
Alzheimers Dement; 2015 Jul; 11(7):860-4. PubMed ID: 26194319
[TBL] [Abstract][Full Text] [Related]
11. Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects.
Trojanowski JQ; Vandeerstichele H; Korecka M; Clark CM; Aisen PS; Petersen RC; Blennow K; Soares H; Simon A; Lewczuk P; Dean R; Siemers E; Potter WZ; Weiner MW; Jack CR; Jagust W; Toga AW; Lee VM; Shaw LM;
Alzheimers Dement; 2010 May; 6(3):230-8. PubMed ID: 20451871
[TBL] [Abstract][Full Text] [Related]
12. Current Landscape of Late-Phase Clinical Trials for Alzheimer's Disease: Comparing Regional Variation Between Subjects in Japan and North America.
Kikuchi M; Adachi N; Matsumaru N; Tsukamoto K
Pharmaceut Med; 2019 Dec; 33(6):511-518. PubMed ID: 31933241
[TBL] [Abstract][Full Text] [Related]
13. The Worldwide Alzheimer's Disease Neuroimaging Initiative: An update.
Hendrix JA; Finger B; Weiner MW; Frisoni GB; Iwatsubo T; Rowe CC; Kim SY; Guinjoan SM; Sevlever G; Carrillo MC
Alzheimers Dement; 2015 Jul; 11(7):850-9. PubMed ID: 26194318
[TBL] [Abstract][Full Text] [Related]
14. Integrating ADNI results into Alzheimer's disease drug development programs.
Cummings JL
Neurobiol Aging; 2010 Aug; 31(8):1481-92. PubMed ID: 20447734
[TBL] [Abstract][Full Text] [Related]
15. Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans.
Saykin AJ; Shen L; Yao X; Kim S; Nho K; Risacher SL; Ramanan VK; Foroud TM; Faber KM; Sarwar N; Munsie LM; Hu X; Soares HD; Potkin SG; Thompson PM; Kauwe JS; Kaddurah-Daouk R; Green RC; Toga AW; Weiner MW;
Alzheimers Dement; 2015 Jul; 11(7):792-814. PubMed ID: 26194313
[TBL] [Abstract][Full Text] [Related]
16. Using the Alzheimer's Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's disease.
Veitch DP; Weiner MW; Aisen PS; Beckett LA; DeCarli C; Green RC; Harvey D; Jack CR; Jagust W; Landau SM; Morris JC; Okonkwo O; Perrin RJ; Petersen RC; Rivera-Mindt M; Saykin AJ; Shaw LM; Toga AW; Tosun D; Trojanowski JQ;
Alzheimers Dement; 2022 Apr; 18(4):824-857. PubMed ID: 34581485
[TBL] [Abstract][Full Text] [Related]
17. Japanese and North American Alzheimer's Disease Neuroimaging Initiative studies: Harmonization for international trials.
Iwatsubo T; Iwata A; Suzuki K; Ihara R; Arai H; Ishii K; Senda M; Ito K; Ikeuchi T; Kuwano R; Matsuda H; ; Sun CK; Beckett LA; Petersen RC; Weiner MW; Aisen PS; Donohue MC;
Alzheimers Dement; 2018 Aug; 14(8):1077-1087. PubMed ID: 29753531
[TBL] [Abstract][Full Text] [Related]
18. Worldwide Alzheimer's disease neuroimaging initiative.
Carrillo MC; Bain LJ; Frisoni GB; Weiner MW
Alzheimers Dement; 2012 Jul; 8(4):337-42. PubMed ID: 22748939
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2.
Jack CR; Barnes J; Bernstein MA; Borowski BJ; Brewer J; Clegg S; Dale AM; Carmichael O; Ching C; DeCarli C; Desikan RS; Fennema-Notestine C; Fjell AM; Fletcher E; Fox NC; Gunter J; Gutman BA; Holland D; Hua X; Insel P; Kantarci K; Killiany RJ; Krueger G; Leung KK; Mackin S; Maillard P; Malone IB; Mattsson N; McEvoy L; Modat M; Mueller S; Nosheny R; Ourselin S; Schuff N; Senjem ML; Simonson A; Thompson PM; Rettmann D; Vemuri P; Walhovd K; Zhao Y; Zuk S; Weiner M
Alzheimers Dement; 2015 Jul; 11(7):740-56. PubMed ID: 26194310
[TBL] [Abstract][Full Text] [Related]
20. Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer's Disease Spectrum.
Liu Y; Tan L; Wang HF; Liu Y; Hao XK; Tan CC; Jiang T; Liu B; Zhang DQ; Yu JT;
Mol Neurobiol; 2016 Sep; 53(7):4539-47. PubMed ID: 26298664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
